Concepedia

Yu Mi

YM

Statistics

Publications

18

Citations

1.4K

H-Index

17

Active since

2011

Affiliations

National University of Singapore(Current)

Carolina Institute for NanoMedicine

University of North Carolina at Chapel Hill

Chinese Academy of Medical Sciences & Peking Union Medical College

Houston Methodist

Yu Mi is an author at National University of Singapore specializing in drug delivery, pharmacy, and nanoparticle drug delivery.

ORCID

Publications per year

2011–2021

18

Publications

18

Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy

Yu Mi, Yutao Liu, Si‐Shen Feng · Biomaterials · 2011 · 260 citations

, , +14

A Dual Immunotherapy Nanoparticle Improves T‐Cell Activation and Cancer Immunotherapy

Yu Mi, Christof C. Smith, Feifei Yang et al. · Advanced Materials · 2018 · 198 citations · Full text

, , +17

Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer

Yu Mi, Jing Zhao, Si‐Shen Feng · Journal of Controlled Release · 2013 · 156 citations

, , +14

Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers

Yu Mi, Xiaoli Liu, Jing Zhao et al. · Biomaterials · 2012 · 121 citations

, , +16

Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles

Jing Zhao, Yu Mi, Si‐Shen Feng · Biomaterials · 2013 · 92 citations

, , +8

1–5 of 18